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3Parkinson's disease (PD) is a multifactorial complex disorder associated with 
motor signs as well as diverse non-motor symptoms such as circadian disruption, 
depression, and cognitive decline. Dysregulation of the hypothalamic-pituitary-
adrenal (HPA) axis, evidenced by hypersecretion of cortisol, is implicated in such 
non-motor symptoms1 and elevated levels of cortisol have been documented in PD, 
especially in the morning2. Participation in physical activity may reduce the risk and 
rate of progression of PD3,4 and endurance exercise may reduce the rate at which 
the signs of PD progress5. Since physical fitness and long term physical activity is 
associated with attenuated cortisol secretion in healthy participants6, we undertook a 
feasibility study to examine the effects of high intensity endurance exercise on 
diurnal salivary cortisol secretion (as well measures of cognition, structural and 
functional brain imaging and blood derived biomarkers) in patients with PD with mild 
cognitive impairment (PD-MCI). We predicted that 6-months of high intensity 
endurance treadmill exercise would generate a measurable decrease in salivary 
cortisol secretion from baseline levels.  
Following ethical approval, eight patients with PD-MCI (5 males), as determined 
by clinical and cognitive assessment (mean MoCA 23.75±2.2), who were not 
exercising at high intensity participated in this study. Participants had mean (SD) age 
of 66.0±8.0 years (range 53-79 years); disease duration based on initial diagnosis of 
5.6±5.4 years (range 1-13 years); Hoehn and Yahr stage 2±0.5 (range 1-3). Using 
best practice guidelines (1-1 instruction; written guidelines; electronic monitoring of 
awakening and saliva sampling collection times)7 participants collected saliva 
samples at home on 2 typical consecutive weekdays before and after the 
intervention. Samples were collected during a post-awakening period (0, 0.25, 0.50, 
40.75 hours after awakening) and a daytime period (3, 6, 9, 12 hours after awakening) 
and were assayed in duplicate (Salimetrics, intra and inter-assay variations <10%).
The intervention involved 6 months of high intensity treadmill exercise and   
included 5-10 min of warm up, 30 min of exercise at 80-85% maximum heart rate, 
followed by 5-10 min of cool down. Participants exercised an average of 2.5 days per 
week (average number of sessions completed: 75±7). During the first 8 weeks of 
training, exercise duration and intensity were gradually increased to target levels. 
Distribution of cortisol data was normalized by square root transformation (raw 
data illustrated). Multi-level modelling compared 2 days pre- vs. 2 days post-
intervention. Mean wake time was 6:03±1 hour 20 minutes and adherence to 
protocol was excellent (modal time of first sample = 3 min post-awakening and 
reported effects were consistent with non-adherent samples omitted). A trend for 
reduced cortisol secretion as averaged across all time points was observed with a 
19% reduction; (p=0.07); this reached statistical significance for the post-awakening 
period (p=0.02), but not for the daytime period (p=0.14). Cortisol secretion in 
participants with PD post-intervention more closely resembled healthy reference data 
post-intervention (Figure 1).
These data support the need for further exploration of HPA axis dysregulation in 
PD, including its non-motor symptoms, to understand not only its potential role in the 
mechanisms underlying non-motor symptoms of PD, but also its responsiveness to  
intervention studies such as physical exercise that can improve non-motor 
symptoms.
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9(12) Figure 1  Legend
Figure 1: Diurnal salivary cortisol concentrations (mean+SEM) pre (circles) 
and post (squares) exercise intervention. Laboratory reference data (triangles) 
from comparable healthy participants are provided for illustrative purposes: 
post-awakening period: n=55, 43F/13M, aged 68.3±8.5; daytime period: n=26, 
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